US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ホーム
投資
株式
イタリア
BIT
Fope (FPE) 銘柄情報

Fope (FPE)

64.00

-2.00

(-3.03%)

終了 7月8日 12:30AM

Fope (FPE) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

64.00

( -3.03% )

買値

63.00

売値

66.00

出来高

1,000

平均取引量 (3 か月)

2,224 €

財務取引量

-

64.00 日の範囲 66.00

36.20 52 週間の範囲 66.00

時価総額

企業価値

343.492M

前日終値

66.00

始値

66.00

時刻

最終取引時間

VWAP

-

歳入

94.39M

純利益

11.38M

発行済株式数

5,434,608

浮動株比率 (%)

9.77%

機関投資家保有比率 (%)

2.57%

配当利回り

(2.02%)

PER

30.95

株価売上高倍率 (PSR)

3.74

1 株当たり利益 (EPS)

2.1

ベータ

0.25

Fope S.p.A. engages in the manufacture and sale of jewellry products under the Fope brand in Italy, Europe, and internationally. The company offers bracelets, rings, necklaces, earrings, watch straps, cufflinks, and other collections for men and women. It also offers fragrance products. The company ... Fope S.p.A. engages in the manufacture and sale of jewellry products under the Fope brand in Italy, Europe, and internationally. The company offers bracelets, rings, necklaces, earrings, watch straps, cufflinks, and other collections for men and women. It also offers fragrance products. The company sells its products through single and multi-brand stores. Fope S.p.A. was founded in 1929 and is headquartered in Vicenza, Italy. 詳細を表示

セクター

Consumer Discretionary

業界

Retail - Discretionary

ウェブサイト

www.fope.com

本社

Vicenza, Italy

設立

2026

Fope is listed in the Consumer Discretionary sector of the イタリア証券取引所 with ticker FPE. The last closing price for Fope was 66.00 €. Over the last year, Fope shares have traded in a share price range of 36.20 € to 66.00 €.

Fope currently has 5,434,608 shares in issue. The market capitalisation of Fope is 347.81 € million. Fope has a price to earnings ratio (PE ratio) of 30.95.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.5	-0.77519379845	64.5	66	62.5	1700	65.08823529	DE
4	14	28	50	66	48.2	2313	61.1027027	DE
12	27.2	73.9130434783	36.8	66	36.2	1877	51.15427136	DE
26	23.8	59.2039800995	40.2	66	36.2	1780	47.57739726	DE
52	26.2	69.3121693122	37.8	66	36.2	1574	44.34717349	DE
156	30.8	92.7710843373	33.2	66	21.4	1481	33.88915409	DE
260	54.6	580.85106383	9.4	66	9.25	1879	25.68008317	DE

FPE - Frequently Asked Questions (FAQ)

What is the current Fope share price?

The current share price of Fope is 64.00 €

How many Fope shares are in issue?

Fope has 5,434,608 shares in issue

What is the market cap of Fope?

The market capitalisation of Fope is EUR 347.81M

What is the 1 year trading range for Fope share price?

Fope has traded in the range of 36.20 € to 66.00 € during the past year

What is the PE ratio of Fope?

The price to earnings ratio of Fope is 30.95

What is the cash to sales ratio of Fope?

The cash to sales ratio of Fope is 3.74

What is the registered address of Fope?

The registered address for Fope is Via Maria Teresa Mioni, 10, Vicenza, Vicenza, 36100

What is the Fope website address?

The website address for Fope is www.fope.com

Which industry sector does Fope operate in?

Fope operates in the Retail - Discretionary sector

Kool Aid Man

Kool Aid Man 8分前

HIRU & HW*AL's auditor izza virtual office/co-working location in Houston

https://www.tsbpa.texas.gov/wp-content/uploads/2025/08/executive_agenda_20250709.pdf

Mokuolou is reportedly here on an H15 work visa.

"The surname Mokuolu has its roots in the Yoru

biotechinvestor1

biotechinvestor1 9分前

Here you go again, cherry picking certain time frames to make your case. Attached is a chart of Halozyme compared to XBI since Halozyme’s IPO and also a five-year chart of Halozyme versus XBI. XBI is the purple line. I will let this board to be the judge.
It’s not just that you were bearish

cancerfreed

cancerfreed 11分前

RDGL needs a marketing customer service person to replace George Sharp who sadly passed recently.
Anyone, pls pass the message to MK who must have been busy with IDE and forgotten about the vacant marketing position to be filled.

3331

BIEL NEWS - THE MONEY IS ROLLING IN!
https://finance.yahoo.com/healthcare/articles/bioelectronics-advances-actipatch-commercial-rollout-141518246.html

joe botts

joe botts 12分前

Once the Buy back takes place says who?????

boston745

boston745 12分前

Conspiracy to Steal Trade Secrets and its Estimated Timeframe as well as potential insider trading.

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

This post is a work in progress. It contains

3331

BIEL NEWS - THE MONEY IS ROLLING IN!
https://finance.yahoo.com/healthcare/articles/bioelectronics-advances-actipatch-commercial-rollout-141518246.html

gotmilk

gotmilk 13分前

something different

Coma (2019/2020)
This Russian sci-fi thriller follows a young architect who wakes up in a surreal, dystopian world after a mysterious car accident. He realizes this strange realm is composed of the overlapping memories and subconscious thoughts of people wh

sandor8

sandor8 14分前

Merveilleux ! Even if I don't know, I know that Mr. K. is and did and will do more than the necessary for KBLB to advance and be generative of fantastic products and 💲💲💲💲💲💲

TradingCharts

TradingCharts 17分前

Here is one I have never seen before.

https://www.klgatesdelawaredocket.com/wp-content/uploads/2016/02/ThermoplylaeCapitalvSimbol.pdf

Bngo

My take on Nasrat’s answer is on the potential tariffs on the APIs to make Elite’s drugs that might affect the merger and acquisitions process.His answer is he does not think so.
However, he also did not say how tariff will affect other foreign drug manufacturers. Logically, it will and with

JohnnyRotton

JohnnyRotton 24分前

Valuation is difficult, should be a market cap of 20 million plus because of revs of 5.8 mil and a 3x price to revenue is almost 20 mil. Plus some gross profit with a pe of 10 would do it. But I don't know debt and current qtr numbers for the subsidiary. I wouldnt promise the moon here. Plus the wh

Moe2001

Moe2001 27分前

I want this to be better than 2021 even better than the 90’s . Let’s witness BCAP make history.

3331

Pathway to the PPS Milestones is Highly Compressed
The recent validation from the June 30, 2026, Chairman’s Update confirms that the strategic distribution partnership with Electrome Corporation has officially moved forward, satisfying initial conditions and executing the first purchase order

MasterBlastr

MasterBlastr 28分前

What a horrible ending - this held such promise.

murrayhill

murrayhill 30分前

nice guitar, Tosh is playing, cap.

Moneysign5

Moneysign5 31分前

People say you may be captain of the fraud squad

TradingCharts

TradingCharts 33分前

John looks heathy in this picture other pictures I worry he will have a heat attack.

https://www.texasmonthly.com/news-politics/lithium-mining-boom-northeast-texas/

SPARK'S FLY

SPARK'S FLY 40分前

Amazing Products.

PennyHeaven7

PennyHeaven7 42分前

Yes but!!!!!!!!!!!, BUT!!! IMO as new revenues start to flow into PSRU, I for one see a share buyback program that will take care of this. what's that saying all things in their time. here is where Patience and sit back and watch comes in for any longs that is. PSRU is not for day traders, that's fo

Joe Kaplan

Joe Kaplan 47分前

Well............Things are not exactly lookiing up at the moment.......

satter

satter 47分前

Decoding the auditor PR: full explanation linked here.

Its not a coincedence it's happening now. It's Court Damage Control.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177767452

Amundi Japan Topix Ii Uc...

JPMorgan USD Emerging Ma...

Firstmac Mortgage Fundin...

Advantex Marketing

Jinhui Shipping and Tran...

Credit Agricole CIB FCIA...

Apartment Investment & M...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。